Navigation Links
U.S. Food and Drug Administration Approves ORENCIA(R) (abatacept) for the Treatment of Moderate-to-Severe Polyarticular Juvenile Idiopathic Arthritis (JIA) in Patients Six Years and Older
Date:4/8/2008

nancy registry has been established to monitor fetal outcomes. Healthcare professionals are encouraged to register pregnant patients exposed to ORENCIA by calling 1-877-311-8972.

Most Serious Adverse Reactions: Serious infections (three percent ORENCIA vs. 1.9 percent placebo) and malignancies (1.3 percent ORENCIA vs. 1.1 percent placebo). In general, adverse events in pediatric and adolescent patients were similar in frequency and type to those seen in adult patients.

Malignancies: The overall frequency of malignancies was similar between adult patients treated with ORENCIA(R) (abatacept) or placebo. However, more cases of lung cancer were observed in patients treated with ORENCIA (0.2 percent) than those on placebo (zero percent). A higher rate of lymphoma was seen compared to the general population; however, patients with RA, particularly those with highly active disease, are at a higher risk for the development of lymphoma. The potential role of ORENCIA in the development of malignancies in humans is unknown.

Most Frequent Adverse Events (greater than or equal to 10 percent): Headache, upper respiratory tract infection, nasopharyngitis and nausea were the most commonly reported adverse events in the adult RA clinical studies.

Please see accompanying Full Prescribing Information or visit http://www.ORENCIA.com or http://www.BMS.com.

About ORENCIA

ORENCIA is indicated for reducing signs and symptoms, inducing major clinical response, inhibiting the progression of structural damage, and improving physical function in adult patients with moderately to severely active RA. ORENCIA may be used as monotherapy or concomitantly with DMARDs other than TNF antagonists. ORENCIA is also indicated for reducing signs and symptoms in pediatric patients aged six years and older with moderately to severely active polyarticular JIA. ORENCIA may
'/>"/>

SOURCE Bristol-Myers Squibb Company
Copyright©2008 PR Newswire.
All rights reserved

Page: 1 2 3 4 5 6 7 8 9 10

Related medicine technology :

1. Ortho Biotech Statement on U.S. Food and Drug Administration Oncologic Drugs Advisory Committee Vote
2. U.S. Food and Drug Administration Approves ABILIFY(R) (aripiprazole) for the Acute Treatment of Manic and Mixed Episodes Associated With Bipolar I Disorder in Pediatric Patients (10 to 17 Years of Age)
3. Northwestern Offers Clinical Research and Regulatory Administration Graduate Certificate Program
4. Supplemental New Drug Application for PREZISTA(TM) Submitted to U.S. Food and Drug Administration
5. Biological Psychiatry Publishes Study Showing VYVANSE Demonstrated Significant Efficacy for Treatment of ADHD for up to 12 Hours After Administration
6. UM Maryland Industrial Partnerships Program Approves 18 Collaborative Research Projects, Worth $4.4 Million, Between University Faculty, State Technology Companies
7. FDA Approves XYZAL(R) (levocetirizine dihydrochloride) Oral Solution for the Relief of Seasonal and Year Round Allergies and Chronic Idiopathic Urticaria
8. FDA Approves MiddleBrooks Amoxicillin PULSYS for Pharyngitis/Tonsillitis in Adolescents and Adults
9. European Commission Approves ATRIPLA(R) (efavirenz 600 mg/emtricitabine 200 mg/tenofovir disoproxil fumarate 300 mg), the First Once-Daily Single Tablet Regimen for Virologically Suppressed Adults With HIV-1 Infection
10. FDA Approves Cymbalta(R) for Maintenance Treatment of Major Depressive Disorder
11. Health Canada Approves ATRIPLA(R) (efavirenz 600 mg/emtricitabine 200 mg/ tenofovir disoproxil fumarate 300 mg), the First Once-Daily Single Tablet Regimen for HIV
Post Your Comments:
*Name:
*Comment:
*Email:
(Date:8/29/2014)... 29, 2014 , Industry ... the inaugural Tweetchat taking place in real-time at ... organised by UBM Live , announces the ... a first of its kind global industry-wide Tweetchat ... supply chain, aimed to stimulate conversations on key ...
(Date:8/28/2014)... , Aug. 28, 2014  Rigrodsky & Long, P.A.: ... Company, Inc. (NYSE: LCI )? , Did you ... 2013 and July 16, 2014, inclusive? , Did you ... Do you want to discuss your rights? ... United States Attorney, Timothy J. MacFall , announces that a ...
(Date:8/28/2014)... 2014 Reportlinker.com announces that a new ... Germany Aesthetic Lasers and Energy Devices ... http://www.reportlinker.com/p02343442/Germany-Aesthetic-Lasers-and-Energy-Devices-Market-Outlook-to-2020.html Germany Aesthetic Lasers and ... GlobalData,s new report, "Germany Aesthetic Lasers and ... market data on the Germany Aesthetic Lasers and ...
Breaking Medicine Technology:CPhI Worldwide to Host #CPhIChat Provoking Debate on the Future of Pharma 2CPhI Worldwide to Host #CPhIChat Provoking Debate on the Future of Pharma 3Rigrodsky & Long, P.A. Announces A Securities Fraud Class Action Lawsuit Has Been Filed Against Lannett Company, Inc. 2Rigrodsky & Long, P.A. Announces A Securities Fraud Class Action Lawsuit Has Been Filed Against Lannett Company, Inc. 3Germany Aesthetic Lasers and Energy Devices Market Outlook to 2020 2Germany Aesthetic Lasers and Energy Devices Market Outlook to 2020 3Germany Aesthetic Lasers and Energy Devices Market Outlook to 2020 4Germany Aesthetic Lasers and Energy Devices Market Outlook to 2020 5Germany Aesthetic Lasers and Energy Devices Market Outlook to 2020 6Germany Aesthetic Lasers and Energy Devices Market Outlook to 2020 7Germany Aesthetic Lasers and Energy Devices Market Outlook to 2020 8Germany Aesthetic Lasers and Energy Devices Market Outlook to 2020 9
(Date:8/29/2014)... FRIDAY, Aug. 29, 2014 (HealthDay News) -- Selling cigarettes ... or illegal tobacco and doesn,t harm sales in small ... problems were predicted by the tobacco industry when it ... in the world to introduce plain packaging for tobacco ... Ireland, New Zealand and the U.K. Researchers surveyed ...
(Date:8/29/2014)... August 29, 2014 Honey Gifts, premium ... company will now be selling purse-sized adult toys and ... way that they can be carried in a woman’s ... the purse-sized range at Honey Gifts is also leak-free ... life and rechargeable batteries are common characteristics of Honey ...
(Date:8/29/2014)... Barbara, CA (PRWEB) August 29, 2014 ... in Santa Barbara in the Santa Barbara News-Press Readers’ ... Evolutions won the Readers’ Choice poll as Best Medical ... 20, 2014 reads the following about Evolutions Medical Spa ... spa, but it is recognized as a top-notch, cutting-edge ...
(Date:8/29/2014)... COLUMBUS, Ohio (PRWEB) August 29, 2014 ... vice president of operations & business development. , Rees ... the vice president of business development. , A wholly ... (OPRS), Senior Independence provides older adults with options, including ... teams, in-home care (e.g., meal preparation) and therapeutic adult ...
(Date:8/29/2014)... Last week, the Fed reported an increase in ... rose to 0.4% while manufacturing output progressed to 1.0%. ... boost since February this year. Capacity use has increased by ... – an increase that could be attributed to the boost ... which is a measure of slack across the industries. , ...
Breaking Medicine News(10 mins):Health News:Study Counters Critics of Plainer Cigarette Packaging 2Health News:Honey Gifts Now Provides Purse Sized Adult Toys in Vancouver 2Health News:Evolutions Named Best Medical Spa in Santa Barbara by Santa Barbara News Press 2Health News:Evolutions Named Best Medical Spa in Santa Barbara by Santa Barbara News Press 3Health News:Senior Independence Promotes Rees to Vice President of Operations & Business Development 2Health News:LeaseQ Announces That Recent Industrial Production Report Spells Good Things For The Equipment Leasing Industry 2Health News:LeaseQ Announces That Recent Industrial Production Report Spells Good Things For The Equipment Leasing Industry 3
... Findings may explain link between breathing in dirty air ... -- Long-term exposure to the air pollution particles caused ... blood pressure, U.S. researchers say. , In the new ... Normative Aging Study, who were assessed every four years ...
... warmer than 75 degrees poses added risks , THURSDAY, March ... deaths in New York City go up with the temperature: ... 75 degrees Fahrenheit. , The findings, published online March ... death statistics in the city from 1990 through 2006. , ...
... ... ... ... ...
... replicate the human brain, or to develop nanotechnology that ... neurons and other types of cellular networks? Once ... other in ways that could propel extraordinary new research. ... an hour-long conversation recently led by neuroscientist Nicholas Spitzer. ...
... , ... ... ... ...
... Henry Ford Hospital study has shown a link between Vitamin ... lead researchers to better understand the development of the most ... researchers at Henry Ford and Wayne State University found elevated ... taken from 10 patients compared to normal skin tissue taken ...
Cached Medicine News:Health News:Years of Exposure to Traffic Pollution Raises Blood Pressure 2Health News:Anthera Pharmaceuticals Completes Initial Public Offering 2Health News:Anthera Pharmaceuticals Completes Initial Public Offering 3Health News:Anthera Pharmaceuticals Completes Initial Public Offering 4Health News:Anthera Pharmaceuticals Completes Initial Public Offering 5Health News:Anthera Pharmaceuticals Completes Initial Public Offering 6Health News:Dermatologists Can Help Women Win the Fight Against Common Forms of Hair Loss 2Health News:Dermatologists Can Help Women Win the Fight Against Common Forms of Hair Loss 3Health News:Dermatologists Can Help Women Win the Fight Against Common Forms of Hair Loss 4Health News:Dermatologists Can Help Women Win the Fight Against Common Forms of Hair Loss 5Health News:Dermatologists Can Help Women Win the Fight Against Common Forms of Hair Loss 6Health News:Dermatologists Can Help Women Win the Fight Against Common Forms of Hair Loss 7Health News:Dermatologists Can Help Women Win the Fight Against Common Forms of Hair Loss 8Health News:Dermatologists Can Help Women Win the Fight Against Common Forms of Hair Loss 9
... scale accommodates standard to extra-wide wheelchairs (18" ... The low-profile, heavy-duty, anodized aluminum weighing platform ... high providing easy access for large patients. ... steel digital readout. The 6772 has the ...
This high-capacity stand-on scale provides extra sensitivity and support to patients who are unsteady on their feet. Advanced technology compensates for patient movement....
... 100 provides a new screening, diagnostic, treatment ... medical management of sleep-related breathing disorders. The ... unmet need for an ambulatory, reliable, patient ... to the great number of OSA sufferers, ...
... synthesized by the parathyroid glands [1,2] ... extracellular calcium concentrations. PTH prevents hypocalcemia ... calcium excretion by the kidney. Following ... is rapidly degraded into 4 fragments: ...
Medicine Products: